Biotage AB Nomination Committee

Biotage AB Nomination Committee

A Nomination Committee consisting of shareholder representatives and the
Chairman of the Board of Directors has been formed for Biotage AB. The
Nomination Committee shall, before the Annual General Meeting 2012,
prepare proposals for the election of Chairman and other members of the
Board of Directors, the election of Chairman of the Annual General
Meeting, election of Auditors, the determination of fees and matters
pertaining thereto.
The members of the Nomination Committee are:
Staffan Josephson, Investor Growth Capital
Anders Walldov, Brohuvudet AB and direct holding
Tommy Jacobsson, Varenne AB
Ove Mattsson, Chairman of the Board, direct holding and holding by
endowment insurance 
Shareholders wishing to submit a proposal for members of the Board of
Directors may do so by sending e-mail to the Chairman of the Board of
Directors of Biotage AB at: info@biotage.com (info@biotage.com)

 
Contact:
Torben Jörgensen, President and CEO
Tel: +46 707 49 05 84,
torben.jorgensen@biotage.com (torben.jorgensen@biotage.com)

The information in this press release is of the kind that Biotage AB
(publ) may be required to make public according to the Securities Market
Act and/or Financial Instruments Trading Act. The information was
released for publication at 8am on October 26, 2011.

About Biotage:
Biotage offers solutions, knowledge and experience in the areas of
analytical chemistry and medicinal chemistry. The customers include the
world's largest pharmaceutical and biotech companies, and leading
academic institutes. The company is headquartered in Uppsala and has
subsidiaries in the US, UK and Japan. Biotage has 272 employees and had
sales of 428.9 MSEK in 2010. Biotage is listed on the NASDAQ OMX Nordic
Stockholm stock exchange. Website:www.biotage.com